Jeffrey L. Ives
Director · Acumen Pharmaceuticals, Inc.
Individual
- 2026
- Jun 5, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jeffrey L. Ives files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Derek M. Meisner - $105K in ABOS purchases and sales in the last 12 months
- Derrell Porter - $75K in ABOS purchases and sales in the last 12 months
- Daniel Joseph Oconnell - $22K in ABOS purchases and sales in the last 12 months
- Nathan B. Fountain - $14K in ABOS purchases and sales in the last 12 months
- Matt Zuga - $8K in ABOS purchases and sales in the last 12 months
- Eric Siemers - $6K in ABOS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jeffrey L. Ives?
Jeffrey L. Ives is a corporate insider, tracked as Director of Acumen Pharmaceuticals, Inc. (ABOS). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Jeffrey L. Ives last file a Form 4?
The only primary Form 4 on record is dated 5 June 2026.
